Literature DB >> 31744377

Brain atrophy in cerebral small vessel diseases: Extent, consequences, technical limitations and perspectives: The HARNESS initiative.

François De Guio1, Marco Duering2,3, Franz Fazekas4, Frank-Erik De Leeuw5, Steven M Greenberg6, Leonardo Pantoni7, Agnès Aghetti1, Eric E Smith8, Joanna Wardlaw9, Eric Jouvent1.   

Abstract

Entities:  

Keywords:  Cerebral small vessel disease; brain atrophy; brain volume; cognitive alterations; cognitive performances; lacunes; segmentation; white matter hyperintensities

Mesh：

Year:  2019        PMID： 31744377      PMCID： PMC7370623          DOI： 10.1177/0271678X19888967

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN： 0271-678X            Impact factor:   6.200


× No keyword cloud information.
  61 in total

1.  Whole-brain atrophy rate and CSF biomarker levels in MCI and AD: a longitudinal study.

Authors:  Jasper D Sluimer; Femke H Bouwman; Hugo Vrenken; Marinus A Blankenstein; Frederik Barkhof; Wiesje M van der Flier; Philip Scheltens
Journal:  Neurobiol Aging       Date:  2008-08-08       Impact factor: 4.673

2.  Reliability of longitudinal brain volume loss measurements between 2 sites in patients with multiple sclerosis: comparison of 7 quantification techniques.

Authors:  F Durand-Dubief; B Belaroussi; J P Armspach; M Dufour; S Roggerone; S Vukusic; S Hannoun; D Sappey-Marinier; C Confavreux; F Cotton
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-12       Impact factor: 3.825

3.  White matter edema at the early stage of cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy.

Authors:  François De Guio; Jean-François Mangin; Marco Duering; Stefan Ropele; Hugues Chabriat; Eric Jouvent
Journal:  Stroke       Date:  2014-11-04       Impact factor: 7.914

4.  Brain atrophy and cerebral small vessel disease: a prospective follow-up study.

Authors:  Arani Nitkunan; Silvia Lanfranconi; Rebecca A Charlton; Thomas R Barrick; Hugh S Markus
Journal:  Stroke       Date:  2010-12-09       Impact factor: 7.914

5.  The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI.

Authors:  P A Freeborough; N C Fox
Journal:  IEEE Trans Med Imaging       Date:  1997-10       Impact factor: 10.048

6.  Cortical changes in cerebral small vessel diseases: a 3D MRI study of cortical morphology in CADASIL.

Authors:  Eric Jouvent; Jean-François Mangin; Raphael Porcher; Anand Viswanathan; Mike O'Sullivan; Jean-Pierre Guichard; Martin Dichgans; Marie-Germaine Bousser; Hugues Chabriat
Journal:  Brain       Date:  2008-06-24       Impact factor: 13.501

Review 7.  Cerebral atrophy in cerebrovascular disorders.

Authors:  Eric Jouvent; Anand Viswanathan; Hugues Chabriat
Journal:  J Neuroimaging       Date:  2009-03-24       Impact factor: 2.486

8.  Accurate automatic estimation of total intracranial volume: a nuisance variable with less nuisance.

Authors:  Ian B Malone; Kelvin K Leung; Shona Clegg; Josephine Barnes; Jennifer L Whitwell; John Ashburner; Nick C Fox; Gerard R Ridgway
Journal:  Neuroimage       Date:  2014-10-01       Impact factor: 6.556

Review 9.  Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging.

Authors:  Joanna M Wardlaw; Colin Smith; Martin Dichgans
Journal:  Lancet Neurol       Date:  2013-05       Impact factor: 44.182

10.  How much do focal infarcts distort white matter lesions and global cerebral atrophy measures?.

Authors:  Xin Wang; Maria C Valdés Hernández; Fergus Doubal; Francesca M Chappell; Joanna M Wardlaw
Journal:  Cerebrovasc Dis       Date:  2012-11-14       Impact factor: 2.762
View more
  10 in total

1.  The Epidermal Growth Factor Domain of the Mutation Does Not Appear to Influence Disease Progression in CADASIL When Brain Volume and Sex Are Taken into Account.

Authors:  J Lebenberg; J-P Guichard; A Guillonnet; D Hervé; N Alili; A Taleb; N Dias-Gastellier; H Chabriat; E Jouvent
Journal:  AJNR Am J Neuroradiol       Date:  2022-04-29       Impact factor: 3.825

Review 2.  Physiology of Glymphatic Solute Transport and Waste Clearance from the Brain.

Authors:  Lucy Zhao; Allen Tannenbaum; Erik N T P Bakker; Helene Benveniste
Journal:  Physiology (Bethesda)       Date:  2022-07-26

3.  Association of autosomal dominant polycystic kidney disease with cerebral small vessel disease.

Authors:  Woo-Jin Lee; Keun-Hwa Jung; Hyunjin Ryu; Kook-Hwan Oh; Jeong-Min Kim; Soon-Tae Lee; Kyung-Il Park; Kon Chu; Ki-Young Jung; Manho Kim; Sang Kun Lee
Journal:  J Cereb Blood Flow Metab       Date:  2021-08-20       Impact factor: 6.960

4.  Loss of the heterogeneous expression of flippase ATP11B leads to cerebral small vessel disease in a normotensive rat model.

Authors:  Sophie Quick; Tessa V Procter; Jonathan Moss; Luise Seeker; Marc Walton; Angus Lawson; Serena Baker; Anna Beletski; Daniela Jaime Garcia; Mehreen Mohammad; William Mungall; Ami Onishi; Zuzanna Tobola; Michael Stringer; Maurits A Jansen; Antoine Vallatos; Ylenia Giarratano; Miguel O Bernabeu; Joanna M Wardlaw; Anna Williams
Journal:  Acta Neuropathol       Date:  2022-05-30       Impact factor: 15.887

5.  Cerebral Microbleeds, Cerebral Amyloid Angiopathy, and Their Relationships to Quantitative Markers of Neurodegeneration.

Authors:  Charles Beaman; Krystyna Kozii; Saima Hilal; Minghua Liu; Anthony J Spagnolo-Allende; Guillermo Polanco-Serra; Christopher Chen; Ching-Yu Cheng; Daniela Zambrano; Burak Arikan; Victor J Del Brutto; Clinton Wright; Xena E Flowers; Sandra P Leskinen; Tatjana Rundek; Amanda Mitchell; Jean Paul Vonsattel; Etty Cortes; Andrew F Teich; Ralph L Sacco; Mitchell S V Elkind; David Roh; Jose Gutierrez
Journal:  Neurology       Date:  2022-02-28       Impact factor: 11.800

6.  Small vessel disease lesion type and brain atrophy: The role of co-occurring amyloid.

Authors:  Rutger Heinen; Onno N Groeneveld; Frederik Barkhof; Jeroen de Bresser; Lieza G Exalto; Hugo J Kuijf; Niels D Prins; Philip Scheltens; Wiesje M van der Flier; Geert Jan Biessels
Journal:  Alzheimers Dement (Amst)       Date:  2020-07-13

7.  Cortical Thickness and Its Association with Clinical Cognitive and Neuroimaging Markers in Cerebral Amyloid Angiopathy.

Authors:  Arsenije Subotic; Cheryl R McCreary; Feryal Saad; Amanda Nguyen; Ana Alvarez-Veronesi; Angela M Zwiers; Anna Charlton; Andrew E Beaudin; Zahinoor Ismail; G Bruce Pike; Eric E Smith
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 8.  Cerebral small vessel disease and vascular cognitive impairment: from diagnosis to management.

Authors:  Maria Clara Zanon Zotin; Lukas Sveikata; Anand Viswanathan; Pinar Yilmaz
Journal:  Curr Opin Neurol       Date:  2021-04-01       Impact factor: 6.283

9.  Changes in local brain function in mild cognitive impairment due to semantic dementia.

Authors:  Liang Cui; Keliang Chen; Lin Huang; Jiawei Sun; Yating Lv; Xize Jia; Qihao Guo
Journal:  CNS Neurosci Ther       Date:  2021-03-02       Impact factor: 5.243

10.  Presumed small vessel disease, imaging and cognition markers in the Alzheimer's Disease Neuroimaging Initiative.

Authors:  Cassidy M Fiford; Carole H Sudre; Alexandra L Young; Amy Macdougall; Jennifer Nicholas; Emily N Manning; Ian B Malone; Phoebe Walsh; Olivia Goodkin; Hugh G Pemberton; Frederik Barkhof; Daniel C Alexander; M Jorge Cardoso; Geert Jan Biessels; Josephine Barnes
Journal:  Brain Commun       Date:  2021-10-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.